# Aarvik Therapeutics, Inc. — Form D

Aarvik Therapeutics, Inc. of Hayward, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-11. The offering totals $15.0M, of which $1.2M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-12-11
- Form: D
- Accession: 0001881431-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $1.2M
- Remaining: $13.8M
- Investors: 5
- Date of first sale: 2024-11-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-531747

## Issuer

- Name: Aarvik Therapeutics, Inc.
- CIK: 0001881431
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 31363 Medallion Drive, Hayward, CA, 94544
- Phone: 408 741-1889

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Anula Jayasuriya | Director | San Francisco, CA |
| Jagath Reddy Junutula | Director | Hayward, CA |
| Ram Kalakoti Reddy | Director | Hayward, CA |
| Richard Scheller | Director | Hayward, CA |
| Sachdev Sidhu | Director | Hayward, CA |
| Jagath Reddy Junutula | Executive Officer | Hayward, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-09-02](https://search.stillhousedata.com/formd/0001881431-21-000001) | D | $8.3M | $8.3M |

## More

- [CIK 1881431 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1881431&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001881431-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.